Screening which avoids needle insertion into prostate gland also used to detect skin or breast cancer
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. Available to its individual, SME and large corporate members, the new approach avoids the invasive routine of taking small samples of tissues for analysis via needle insertion into the prostate gland through the wall of the rectum, which misses cancer 50% of the time and can often lead to infection. Prostate cancer is the most common cancer in men and, according to Prostate...
Insurers have ability to use AI, but often choose not to
New research with The Exeter
Leading With Distinction